جستجوی استاد راهنمای دانشگاهی

Steff Lewis is a Professor of Medical Statistics at the University of Edinburgh , affiliated with the Usher Institute within the College of Medicine and Veterinary Medicine . She leads the statistics group at the Edinburgh Clinical Trials Unit and holds roles in the Deanery of Molecular, Genetic and Population Health Sciences . Her expertise spans meta-analysis, randomized trial design, and clinical trial governance, with involvement in Cochrane Collaboration and UK Clinical Research Collaboration initiatives. Education: MSc and PhD in Medical Statistics. Research Interests: Focuses on methodological advancements in clinical trial reporting (e.g., CONSORT and SPIRIT guidelines), cardiovascular outcomes (e.g., SCOT-HEART trial), stroke prevention (ASPIRING trial), and ethical data management. She actively contributes to international standards for trial protocols, anonymization practices, and statistical validation. Recent Contributions: Over 200 peer-reviewed articles and 37 ongoing projects, including leadership in trials assessing antiplatelet therapies, Paget’s disease interventions, and pediatric asthma treatments. Collaborates globally on guidelines for randomized trials and data-sharing protocols. Grants & Teams: Principal or co-investigator on projects funded by NIHR, BHF, and ESRC, including trials on iron therapy in critical care (INTACT-2) and cannabinoid treatments for endometriosis pain (ENDO-CAN). Leads multidisciplinary teams integrating statistical rigor with clinical innovation. Labs/Teams: Embedded within the Edinburgh Clinical Trials Unit and the Centre for Population Health Sciences , fostering collaborative research across molecular, genetic, and public health domains.

• Medical Statistics
• Clinical Trials
• Epidemiology
• +۳ مورد دیگر

Professor John Eu-Li Wong serves as Senior Vice President (Health Innovation & Translation) at the National University of Singapore (NUS) and Senior Advisor to the National University Health System (NUHS). Previously, he held pivotal roles including Dean of NUS's Yong Loo Lin School of Medicine (2003-2011), Senior Vice President (Health Affairs), and Director of the National University Cancer Institute. His leadership has been instrumental in developing Singapore's Health and Biomedical Sciences initiative through strategic international partnerships. His educational background includes an MBBS from NUS, residency and fellowship at New York Hospital-Cornell Medical Center (where he served as Chief Resident in Medicine), and specialized training at Memorial Sloan-Kettering Cancer Center. He maintains active clinical expertise as a medical oncologist-haematologist. Professor Wong's research spans comprehensive cancer centers , healthy longevity initiatives , and value-based healthcare systems . His work focuses on translating biomedical research into national health strategies, with particular emphasis on global health security , academic health system integration , and cancer clinical trials infrastructure . He champions multinational collaborations to address transnational health challenges through frameworks like the Cancer Therapeutics Research Group. His scholarly output demonstrates consistent leadership in global health policy and translational medicine , with recent publications addressing pandemic response systems (2020), genomic medicine implementation (2015), and sustainable healthcare models (2021-2022). The work reveals a strategic shift toward healthy longevity roadmaps and value-based healthcare ecosystems while maintaining foundational focus on cancer therapeutics. International Member, US National Academy of Medicine (2019) Doctor Philosophiae Honoris Causa, Hebrew University of Jerusalem (2019) President’s Science & Technology Medal, Singapore (2014) Public Administration Medal (Gold), Singapore National Day Awards (2016) Fellow of Royal Colleges of Physicians (London, Edinburgh) and American College of Physicians Professor Wong co-founded the multinational Cancer Therapeutics Research Group (nine institutions) and serves on editorial boards for JAMA and American Journal of Medicine. His grant leadership includes directing Singapore's National University Cancer Institute and spearheading the Global Genomic Medicine Collaborative. Current initiatives focus on the National Academy of Medicine's Healthy Longevity Roadmap and Qatar's Academic Medicine Advisory Board. He established the Cancer Therapeutics Research Group and maintains strategic partnerships with Karolinska Institute, University of Cambridge, Harvard, and Stanford. His leadership extends to the M8 Alliance of Academic Health Centers (past World Health Summit President) and Global Genomic Medicine Collaborative Steering Committee, driving transnational research infrastructure.

• Comprehensive cancer centres
• Healthy longevity
• National health and biomedical sciences research strategy
• +۴ مورد دیگر

Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She is an NHMRC Leadership Fellow (2021–2025) and a Chief Investigator for the NHMRC Centre of Research Excellence in Pulmonary Fibrosis and the NHMRC Centre of Research Excellence in Treatable Traits. Her research focuses on supportive therapies for chronic respiratory diseases, particularly COPD and pulmonary fibrosis, with a strong emphasis on pulmonary rehabilitation, telerehabilitation, and ambulatory oxygen therapy. Her research interests include: Respiratory physiotherapy Pulmonary rehabilitation (home-based and low-cost models) Access to care for chronic lung disease Telerehabilitation and digital health Symptom management in interstitial lung disease Exercise training and physical activity promotion Her recent publications focus on symptom management, digital self-management tools, treatable traits models, and clinical trials in pulmonary fibrosis and COPD. The body of work reflects a strong trend toward patient-centered, accessible, and evidence-based interventions that improve quality of life and clinical outcomes in chronic respiratory conditions. Her major scientific awards include: Society Medal, Thoracic Society of Australia and New Zealand (2021) European Respiratory Society Gold Medal for Allied Health Professionals (2022) NHMRC Investigator Fellow (Leadership 1) (2021) Fellow, Thoracic Society of Australia and New Zealand (2019) American Thoracic Society Pulmonary Rehabilitation Assembly Award (2016) Anne Holland supervises PhD students and is actively involved in advising and grant leadership. She is the Primary Chief Investigator on major trials such as the PERFORM trial and the TAPPET trial, and she leads a multinational ambulatory oxygen trial for fibrotic lung disease. Her work is supported by NHMRC and international collaborations. She is also President of the Thoracic Society of Australia and New Zealand, reflecting her leadership in the field. Anne leads the Holland Respiratory Care Research Group at Monash, which focuses on innovative models of care delivery, validation of remote monitoring tools, and improving patient self-management in chronic lung disease. The team collaborates widely across Australia and internationally, particularly in trials involving pulmonary rehabilitation and treatable traits.

• Respiratory Physiotherapy
• Pulmonary Rehabilitation
• COPD
• +۷ مورد دیگر

Associate Professor Jenni Ilomaki holds a position at Monash University's Centre for Medicine Use and Safety. With expertise in clinical pharmacy, epidemiology, and public health, she leads a research group analyzing administrative claims data. Her work spans collaborations with governmental and non-governmental organizations globally, yielding over 150 peer-reviewed publications and $4 million in grants. She previously served as Chair of ASCEPT's Pharmacoepidemiology Special Interest Group and currently serves as Science Lead for the Monash Addiction Research Centre and Executive Editor of the British Journal of Clinical Pharmacology. Education includes a Bachelor of Science (Pharmacy) from the University of Kuopio (1999) and Master of Science (Pharmacy) from the University of Kuopio (2004). She completed a PhD in alcohol epidemiology at the University of Eastern Finland (2011) and a postdoc at the University of South Australia (2011-2014). Notable recognitions include Young Epidemiologist of the Year (2011) and the Ronald D. Mann Best Paper Award (2021). Key research focuses on quality use of medicines, medicine safety, large population studies, and innovative epidemiological methods. Major projects include developing clinical decision support tools for cardiovascular prevention, analyzing preventable hospitalizations in aged care, and investigating psychotropic medication trends in youth. Her work contributes to UN Sustainable Development Goals related to health equity and non-communicable disease reduction. Recent publications emphasize drug repurposing (e.g., SGLT2 inhibitors), opioid prescribing patterns, hip fracture outcomes, and dementia detection algorithms. She chairs multinational studies on stroke and myocardial infarction cost burdens, demonstrating interdisciplinary impact across pharmacology, epidemiology, and health economics.

• Clinical Pharmacy
• Pharmacoepidemiology
• Public Health
• +۳ مورد دیگر

Dr Claire O'Neill is a Senior Research Fellow at the Swansea University Medical School, specializing in Health Data Science. She is the Manager of the South West Wales Research Design and Conduct Service, funded by Health and Care Research Wales, and has over 15 years of post-doctoral experience in health services research and clinical trials. Research Expertise: Trials, Qualitative Methods, Health Services Research Committee Involvement: Member of Swansea University Health Board’s Joint Scientific Research Committee Research Themes include the integration of clinical trials with qualitative data in emergency medicine, trauma care, and healthcare policy. Her work focuses on blunt chest trauma, self-treatment of COPD exacerbations, and sun safety policies in Welsh schools. Publications highlight trials like STUMBL and ELECT2, emphasizing feasibility studies and patient-clinician communication in trauma management. She also explores health-related quality of life assessments and third-sector influence on NHS Wales. Teaching: Leads module PM-353: Introduction to Clinical Trials , covering trial methodology and responsible reporting of outcomes. Supervision: Available for postgraduate supervision in health data science and clinical research areas.

• Clinical Trials
• Qualitative Methods
• Health Services Research
• +۳ مورد دیگر

George Hripcsak is the Vivian Beaumont Allen Professor of Biomedical Informatics and Director of Medical Informatics Services at New York-Presbyterian Hospital, Columbia University. He holds affiliations with the Vagelos College of Physicians and Surgeons and the Data Science Institute (DSI). His expertise spans clinical informatics, electronic health records (EHRs), and medical knowledge representation standards. Hripcsak earned degrees in chemistry, medicine, and biostatistics, and is a board-certified internist. Research focuses on leveraging EHR data for clinical research and patient safety through data mining and causal inference techniques. Notable contributions include the Arden Syntax (a national standard for medical knowledge representation) and leadership in the Observational Health Data Sciences and Informatics (OHDSI) network. He chairs the AMIA Standards Committee and has advised federal health informatics policies under HIPAA. His academic awards include Fellowships in the American College of Medical Informatics (1995) and New York Academy of Medicine. Current projects emphasize federated learning, genomic risk prediction, and large-scale real-world evidence analysis through initiatives like LEGEND-T2DM and All of Us Research Program. Educations: MD, Biostatistics, Chemistry Labs/Teams: OHDSI, DSI, Medical Informatics Services Grants & Funding: Not explicitly listed in provided texts

• Biomedical Informatics
• Electronic Health Records (EHRs)
• Data Mining
• +۴ مورد دیگر

Ajay Pillarisetti is an Assistant Professor at the University of California, Berkeley's School of Public Health, Department of Environmental Health Sciences. His research focuses on the interplay between household energy use, air pollution exposure, health outcomes, and climate change in low- and middle-income countries. A graduate of UC Berkeley (PhD) and Emory University (MPH, BS), he has led global projects in India, Mongolia, Nepal, Guatemala, Peru, and Rwanda. PhD – Environmental Health Sciences, UC Berkeley MPH – Global Environmental Health, Emory University BS – Biology, Emory College His work employs low-cost air quality sensors, longitudinal surveys, and randomized controlled trials like the HAPIN study to assess health impacts of clean fuel interventions. Key subfields include exposure assessment, implementation science, pollution's metabolic effects, and policy-driven energy transitions. He collaborates with teams across four continents and has published extensively on household air pollution's multi-scale health burdens. Recent articles (2023–2025) highlight trends in quantifying PM2.5's health effects, optimizing sensor networks, and evaluating LPG interventions for maternal/child health. His studies span Guatemala's RESPIRE cohort, Rwanda's HAPIN trial, and India's community monitoring systems, addressing gaps in exposure-response modeling, biomarker analysis, and policy advocacy.

• Household Energy Use
• Air Pollution Exposure
• Human Health Impacts
• +۵ مورد دیگر

Paul Gilbert is an Honorary Professor at the School of Psychology, University of Queensland. As a pioneer of Compassion Focused Therapy (CFT), his work integrates evolutionary, social, developmental, and neurobiological perspectives to address mental health challenges. He maintains an active research profile with recent collaborations spanning multinational studies on compassion-based interventions. Gilbert's research focuses on the mechanisms and applications of compassion in clinical, educational, and community settings. Key areas include reducing shame and self-criticism, developing compassion training protocols for specific populations (e.g., teachers, adolescents, forensic groups), and exploring evolutionary underpinnings of psychopathology. His work frequently employs randomized controlled trials and meta-analytical approaches to validate therapeutic efficacy. Analysis of Gilbert's 15 most recent articles (2023-2024) reveals three dominant themes: 1) Efficacy of compassion-focused interventions across diverse populations (clinical disorders, educational settings, forensic contexts), 2) Integration of contemplative practices (mindfulness, Buddhist psychology) with evolutionary models, and 3) Physiological and neural correlates of compassion and emotional regulation. Methodologically, these studies emphasize mixed-methods designs, scale validation, and cross-cultural applications.

• Compassion Focused Therapy
• Evolutionary Psychology
• Clinical Psychology
• +۴ مورد دیگر

Hannah Wunsch is a Professor of Anesthesiology at Weill Cornell Medical College , Cornell University. She serves as an Attending Anesthesiologist at NewYork-Presbyterian/Weill Cornell Medical Center. M.D. from Washington University School of Medicine (2003) M.Sc. from London School of Hygiene and Tropical Medicine (2002) A.B. from Harvard University (1997) Her research focuses on critical care medicine , with particular emphasis on sepsis outcomes , mechanical ventilation practices , opioid use in postoperative and ICU settings , and health services research utilizing large administrative datasets. Key trends in her recent publications include ICU staffing models , opioid prescription patterns , mechanical ventilation strategies , and long-term outcomes after critical illness . She has published extensively in top-tier journals like Critical Care Medicine , JAMA , and The Lancet .

• Critical Care Medicine
• Anesthesiology
• Sepsis
• +۶ مورد دیگر

Dr. Anna-Maria Platschek is an academic staff member at the Institute of Movement and Neurosciences (German Sport University Cologne). Her research focuses on cancer-related fatigue , cognitive impairments , and exercise interventions for pediatric oncology patients. She collaborates extensively with institutions like the Institute of Cardiology and Sports Medicine and researchers including Thomas Abel , Saskia Henckert , and Hans-Georg Predel . Awards : Outstanding Trainee Research Award (MASCC Fatigue Study Group, 2019) Multiple Reisestipendium awards (2013–2022) Projects : ExerBrain Study (2024–2027) MORE! Move & Relax! (2020–2023) ChiMove (2016–2020) Her work bridges neuroscience and sports medicine , aiming to improve quality of life for children undergoing cancer therapy through tailored physical interventions.

• Pediatric Oncology
• Cancer-Related Fatigue
• Cognitive Impairments
• +۳ مورد دیگر

Karl-Heinz Wagner is Full Professor of Nutrition and Food Quality at the University of Vienna, Faculty of Life Sciences, Department of Nutritional Sciences. He directs an experimental research group investigating how lifestyle factors—diet, specific food components, phytochemicals, physical activity and bioactive non-food compounds—modulate oxidative stress and DNA stability in humans, with emphasis on aging and sarcopenia. He initiated the university-wide “Active Ageing” research platform and coordinates EU projects such as SHIFT2HEALTH. Education & Affiliations: University of Vienna, Faculty of Life Sciences, Department of Nutritional Sciences – Professor and Chair of Nutrition and Food Quality Principal investigator of the Emerging Field “Oxidative Stress and DNA Stability” Head of the “Active Ageing” research platform activeageing.univie.ac.at Research Focus: Prof. Wagner’s group applies state-of-the-art biochemical and molecular techniques to quantify antioxidant compounds, ROS-induced DNA and chromosomal damage, DNA repair capacity and transcriptional regulation of antioxidant defenses. Human intervention trials, cross-sectional cohorts and in-vitro models are used to examine: Impact of plant-based vs. animal-based diets on multimorbidity risk Nitrate-rich beetroot juice effects on microbiome, vascular function and oxidative stress Bilirubin biology and metabolic health in Gilbert’s syndrome High-protein nutrition and resistance training on DNA damage and muscle quality in older adults Microbiota-derived metabolites that enhance CD8 T-cell antitumor immunity after exercise Publication Trends 2023-2025: Recent output demonstrates a strategic shift toward multi-omics integration (metabolomics, lipidomics, proteomics) to dissect diet–microbiome–immune crosstalk and to identify predictive biomarkers of healthy ageing. Papers consistently appear in top-tier journals (Cell, Lancet Healthy Longev, Redox Biol, Mol Nutr Food Res) and embrace large multinational cohorts, randomized controlled trials and mechanistic animal/cellular work. Funding & Networks: Research is mainly funded by the Austrian Science Fund (FWF), National Bank, European Commission (Horizon 2020, Horizon Europe), EU Cross-Border Co-operation and the University of Vienna. A dense national and international partner network ensures continuous biomarker development and knowledge transfer. Student Training & Citizen Science: Prof. Wagner actively involves MSc/PhD students and post-docs in externally funded projects and advertises internships via ERASMUS+. Study participant recruitment portals for projects like SHIFT2HEALTH, NUTRIAGING and bilirubin clinical studies are maintained to engage the public and foster translational impact.

• Oxidative stress and DNA stability
• Molecular nutrition and phytochemicals
• Dietary antioxidants and aging
• +۵ مورد دیگر

Carol Lane is a Visiting Professor at the University of Surrey, affiliated with the Faculty of Engineering and Physical Sciences and the Faculty of Health and Medical Sciences. She holds a PhD in Clinical Neuroscience from the University of British Columbia and additional qualifications in medicine and management from institutions like McGill University and the Institute of Directors. Education: PhD Clinical Neuroscience, University of British Columbia MSc Psychiatry, McGill University Chartered Director (ICD.D), Institute of Directors Her research focuses on translational medical research, integrating engineering and physical sciences with medical applications. Key areas include PET/MRI imaging, medical device development, and pharmaceutical R&D. She also leads initiatives like the Mapping of Health and Medical Research Assets at Surrey and co-supervises PhD research in Quantum Biology and Artificial Retinas. Carol has been recognized with the Tony Jeans Inspirational Teaching Prize and is an Honouree of Women In™ Science . Her work bridges academia and industry, with collaborations involving the NHS, NIHR, and multinational entities like King Abdulla Economic City (Saudi Arabia). Her teaching spans engineering leadership, research methods, and neuroimaging, while her grants include Leverhulme-funded projects and AI-driven traffic control studies. She also serves as a non-executive director in healthcare and R&D sectors.

• Medical Imaging (PET/MRI)
• Research Management
• Medical Device R&D
• +۵ مورد دیگر

Jennifer J. Manly, PhD is a Professor of Neuropsychology at Columbia University, with joint appointments in the Department of Neurology, Gertrude H. Sergievsky Center, and Taub Institute for Research on Alzheimer's Disease and the Aging Brain. Her research focuses on structural and social determinants of cognitive aging disparities, particularly among Black and Latinx communities. Education: Doctorate from University of California San Diego, Internship at Brown University/Miriam Hospital Leadership: MPI of Columbia Interdisciplinary Research Center on Alzheimer’s Disparities Service: Member of National Advisory Council on Aging (2021-present), HHS Alzheimer's Advisory Council (2011-2015) Her work examines how educational opportunities, discrimination, and socioeconomic inequality across the lifecourse affect cognition and brain health later in life. She has developed culturally adapted cognitive assessments and investigates the relationship between literacy and brain function in low-literacy populations. Recent publications analyze Tau PET imaging patterns, dietary interventions for cognitive decline, and harmonization of global cognitive assessment protocols. Her team employs multi-ethnic community studies, familial risk factor analyses, and neuroimaging biomarker validation. Scientific Awards: Tony Wong Diversity Award (2014) International Neuropsychological Society Career Mentoring Award (2020) Irving Institute Senior Mentor of the Year (2022) Dorathe Frick Memorial Award (1994) APA Division 40 Early Career Award (2003) National Academy of Neuropsychology Early Career Award (2006) Dr. Manly's research has received continuous NIH funding and Alzheimer’s Association support. She mentors early-career scientists from minoritized backgrounds and contributes to national policy through advisory council memberships.

• Cognitive Aging
• Neuropsychology
• Health Disparities
• +۴ مورد دیگر

D. (Dick) de Zeeuw is a Professor at the Department of Clinical Pharmacy and Pharmacology, Faculty of Medical Sciences, University of Groningen. He focuses on diabetes-related kidney disease, cardiovascular pharmacology, and clinical trial design. Affiliation : University of Groningen, Faculty of Medical Sciences Role : Professor in Clinical Pharmacy and Pharmacology His research targets chronic kidney disease (CKD) in diabetic patients, exploring: Mechanisms of kidney failure progression Pharmacotherapeutic interventions (SGLT2 inhibitors, RAAS blockers, aldosterone synthase inhibitors) Risk stratification through biomarkers (albuminuria, eGFR dynamics) Cardiorenal protective effects Racial/geographic variability in treatment responses Recent studies include Phase I/II trials of BI 690517 (aldosterone synthase inhibitor) and CANPIONE trial analyzing canagliflozin's impact on pre-intervention eGFR slopes. Collaborative work spans multinational clinical meta-analyses. Scientific contributions: Systematic reviews of ACE/ARB use in advanced CKD Development of prognostic imaging biomarkers for diabetic kidney disease (iBEAt protocol) Validation of biomarkers in PROVALID cohort Analysis of diuretic effects on fluid retention markers

• Diabetes
• Chronic Kidney Disease
• Cardiovascular Medicine
• +۴ مورد دیگر

Associate Professor Hannah Wardill is an NHMRC EL2 Investigator at the University of Adelaide, affiliated with the Faculty of Health and Medical Sciences and SAHMRI. She leads the Supportive Oncology Research Group, focusing on improving cancer patients' health through innovative supportive care solutions. Her research spans microbiome science, clinical oncology, and genetic medicine, with landmark trials like CANCAN, GENESCREEN, and MYWELL. Education: PhD in Biomedicine from the University of Adelaide (2016), followed by a CJ Martin Fellowship at the University of Groningen (Netherlands). Current roles include Vice Chair of MASCC's Mucositis Study Group and Chair of the Cancer Symptoms Trials Group's Gut Dysfunction Node. Research interests center on mitigating long-term effects of cancer treatment, including chemotherapy-induced side effects, microbiota dysbiosis, and mental health interventions. She has attracted over $15M in funding, including an NHMRC Investigator Grant until 2029. Awards include the University of Adelaide Alumni Award, Australian of the Year Finalist (SA Top 4), and South Australian Tall Poppy of the Year. She supervises 3 staff, 1 postdoc, and 6 HDR students, with a focus on nurturing early-career researchers. Community engagement includes founding pooisnottaboo.com and active roles in patient advocacy through MASCC's Patient Partnership Committee.

• Supportive Cancer Care
• Microbiome Science
• Clinical Oncology
• +۴ مورد دیگر